arrow
F

Filippo Tommaso Gallina

regina elena national cancer institute
H指数:12
被引数:447

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysis

新辅助化疗免疫疗法治疗可切除非小细胞肺癌的手术结果:一项系统评价和荟萃分析

2026-04-160
PRE
Validation of the 9th Edition of the TNM Classification in Patients with NSCLC and Lymph Node Involvement: A Retrospective, Multicentric, Observational Study

第九版TNM分类在伴有淋巴结受累的NSCLC患者中的验证:一项回顾性、多中心、观察性研究

Cancers
IF4.4
2026-02-200
OA
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials

在可切除非小细胞肺癌患者中使用佐剂、新辅助和围手术期免疫治疗为基础的治疗方案的损耗情况。前瞻性试验的荟萃分析

2025-09-220
PREAI
VALUE Trial: Phase 1 Safety and Feasibility Study of Same-Day Discharge After VATS Lung Resection

VALUE试验:经胸腔镜肺切除术后当日出院的1期安全性与可行性研究

2025-08-060
PRE
TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma

TP53共突变增加了EGFR突变的Ⅰ期肺腺癌的复发风险。

2025-07-100
PRE
Spatial transcriptomics highlights B cells as key contributors to a complete and durable response to chemo-immunotherapy in a patient with resectable NSCLC

空间转录组学凸显B细胞作为对可切除非小细胞肺癌患者化疗免疫治疗产生完全且持久应答的关键贡献者。

2025-05-110
OA
Technical Innovations and Complex Cases in Robotic Surgery for Lung Cancer: A Narrative Review

肺癌机器人手术中的技术创新与复杂病例:一项叙事性综述

2025-04-220
OA
Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma

间变性淋巴瘤激酶重排早期肺腺癌患者的预测和预后因素

2024-11-120
PRE
Robotic thymectomy in thymic tumours: a multicentre, nation-wide study
2024-04-255
PRE